Use of Mobile application in the management of cancer

Medical Technology based smartphone application in the management of cancer - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066398

Enrollment

204

Registered

2024-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C184- Malignant neoplasm of transverse colon

Interventions

Intervention1: Android Mobile application named Onco care: Intervention group receives access to the smartphone application developed and validated for cancer chemotherapy patients Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: The study includes cancer patients undergoing chemotherapy at JSS Hospital. Only those patients who have informed consent will be included in the study.

Exclusion criteria

Exclusion criteria: Patients with severe complications and those who do not have access to a smartphone will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Treatment adherence levels among cancer patients undergoing chemotherapyTimepoint: Treatment adherence levels among cancer patients undergoing chemotherapy after 6 months of intervention	—

Secondary

Measure	Time frame
Quality of life scores among cancer patients undergoing chemotherapyTimepoint: This will be measured using the EORTC Q-30 questionnaire, which is a validated 30-item tool often used in cancer trials to assess health-related quality of life 6 months of intervention.	—

Countries

India

Contacts

Public ContactDr Sunil Kumar D

JSS Medical College

hariprakash607@gmail.com7306789341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026